Gelonghui May 5th 丨Some investors asked Hailey Biotech (603718.SH) on the investor interactive platform, “Does your company have any bird flu-related products?”
Hailey Biotech replied that the company has a new veterinary drug certificate for the avian influenza DNA vaccine (H5 subtype, pH5-GD), but has not obtained the relevant production approval, so it has not yet produced and sold it